C3肾小球病在肾移植后2年内系列活检中早期复发
该回顾性研究分析18例因C3G(12例C3GN,6例DDD)接受肾移植的患者,中位随访37个月。16例(89%)在中位33天复发,38%通过方案活检发现,仅31%患者蛋白尿>300 mg/g。复发主要依靠免疫荧光和电镜诊断,组织学改变轻微,短期移植物存活良好。
要点
- C3G肾移植后复发率高达89%,且多发生在移植后早期(中位33天)。
- 方案活检可发现约38%的复发病例,仅31%患者出现>300 mg/g蛋白尿。
- 免疫荧光和电镜对早期亚临床复发的诊断至关重要。
核心结论
- 多数因C3G导致原肾衰竭的患者在肾移植后极早期出现疾病复发,通常蛋白尿轻微、组织学改变轻,短期移植物存活良好。
- 免疫荧光和电镜在检测早期亚临床复发中起关键作用,C3GN和DDD复发特征显著重叠。
研究设计与样本
- 回顾性分析2016年1月至2023年1月接受肾移植的18例因C3G(12例C3GN,6例DDD)导致原肾衰竭的患者。
- 收集体学、遗传、临床和病理数据,并使用NanoString 770基因PanCancer免疫分析面板进行转录组分析。
- 主要结局为疾病复发。
主要发现
- 中位随访37(18–56)个月,16例(89%)患者复发(11例C3GN,5例DDD),中位复发时间33(13–141)天。
- 38%复发病例通过方案活检发现,仅31%患者蛋白尿>300 mg/g。
- 复发时组织学改变轻微,无特征性转录组信号,随时间组织学慢性化指数增加,但随访结束时所有移植物均有功能。
- C3GN和DDD复发病例的免疫荧光和电镜表现重叠,复发率和复发时间相似。
临床怎么用
- 肾移植后应早期进行方案活检以发现亚临床复发。
- 诊断早期复发需依赖免疫荧光和电镜检查。
- C3G复发早期蛋白尿可能轻微,不能仅凭蛋白尿判断复发。
局限性
- 样本量较小(18例),为回顾性研究。
- 随访时间较短(中位37个月),缺乏长期移植物存活数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: C3 glomerulopathy (C3G), which encompasses C3GN and dense deposit disease (DDD), results from dysregulation of the alternative complement pathway. Data on disease recurrence after kidney transplantation are limited, and details on histologic features of recurrent C3G are scarce. We aimed to evaluate C3G recurrence in the allograft, with a focus on histologic presentation and progression. METHODS: We retrospectively analyzed 18 patients with native kidney failure attributed to C3G (12 C3GN and six DDD), who received a kidney transplant from January 2016 to January 2023. Demographic, genetic, clinical, and histologic data were studied. The NanoString 770 genes PanCancer Immune Profiling Panel was used for transcriptomic analysis. Disease recurrence was the primary outcome. RESULTS: During a median (interquartile range) follow-up period of 37 (18–56) months, C3G recurrence occurred in 16 (89%) patients (11 with C3GN and five with DDD) at a median (interquartile range) of 33 (13–141) days after transplantation. Over a third (38%) of recurrent cases were detected in protocol biopsies, and only 31% of patients presented with >300 mg/g of proteinuria. Recurrence in index biopsies was mainly established through a combination of immunofluorescence and electron microscopy findings, while it showed only subtle histologic alterations and no characteristic transcriptomic signals. Over time, histologic chronicity indices increased, but all the allografts were functioning at the end of follow-up. Patients with recurrence of C3GN and DDD showed overlapping immunofluorescence and electron microscopy findings and had similar recurrence rate and time to recurrence. CONCLUSIONS: Most of the patients with native kidney failure attributed to C3G developed disease recurrence very early after kidney transplantation, usually with minimal proteinuria, mild histologic alterations, and favorable short-term allograft survival. Immunofluorescence and electron microscopy played a crucial role in detecting early, subclinical recurrence of C3GN and DDD, which showed significant overlapping features.
引用
- Tarragón B, Peleg Y, Jagannathan G, et al. C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation. Clin J Am Soc Nephrol. 2024. PMID: 39116277. doi:10.2215/CJN.0000000000000474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。